<DOC>
	<DOC>NCT01259128</DOC>
	<brief_summary>The purpose of this study is to determine if SER120 nasal spray is well tolerated in 75 years or older nocturic patients.</brief_summary>
	<brief_title>Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With Nocturia</brief_title>
	<detailed_description>Patients entering the study are randomized to either Level 1 SER120 nasal spray concentration or Level 2 SER120 nasal spray concentration</detailed_description>
	<mesh_term>Nocturia</mesh_term>
	<criteria>Male &amp; female greater or equal to 75 years of age, history of nocturia CHF, Diabetes, Diabetes Insipidus, Renal Insufficiency, Heptatic Insufficiency, Incontinence, Illness requiring steroid, current or past urologic maliganancy, nephrotic syndrome Unexplained pelvic masses Urinary bladder surgery or radiotherapy Sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>